Phase I Study of Tremelimumab (Trem) in Combination with Gefitinib (Gef) in Epidermal Growth Factor Receptor Mutant (Egfr-Mut) Non-Small Cell Lung Cancer (Nsclc)
2018 ◽
Vol 7
(S4)
◽
pp. S377-S380
◽
2017 ◽
Vol 99
(2)
◽
pp. E504-E505
2014 ◽
Vol 140
(12)
◽
pp. 2135-2142
◽